Senores Pharmaceuticals Ltd. Financials

15:51 Jul 18

Senores Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
624.35
+2.15 (+0.35%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Senores Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
624.35
+2.15 (+0.35%)
15:51 Jul 18
Quality
image/svg+xml

0/100
Not Eligible

Valuation
image/svg+xml

2/100
Expensive Valuation

Technical

45/100
Technically Neutral

Strength

9

Weakness

9

Opportunity

0

Threats

1

7.44 %

ROE %

4.77 %

ROA %

0.00

EPS

170.72

BVPS

14.70 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
14.17 35.34 214.52 398.25
Operating Expenses +
12.23 22.66 172.93 308.55
Raw Material
10.43 13.24 102.26 181.46
Increase Decrease in Cost
-2.4 -0.48 3.88 -0.76
Other Manufacturing Expense
0 0 0 0
Employee Cost
2.86 4.79 35.46 60.37
Miscellaneous Expenses
22.2 30.91 171.93 247.12
Operating Profit
1.94 12.68 41.59 89.7
Other Income
0.46 3.68 2.82 19.26
Depreciation
0.7 1.78 10.02 16.84
Interest
0.56 2.14 9.45 21.55
Profit before tax and exceptio..
1.14 12.44 24.94 70.57
Exceptional Items
0 0 0 0
PBT
1.14 12.44 24.94 70.57
Provision for Taxation
0.15 4 -7.76 12.23
Net Profit
0.99 8.43 32.71 58.34
NET Profit after MI
0.99 8.43 31.46 58.56
EPS
1.81 8.87 13.67 16.12
Operating Profit Margin (%)
13.69 35.88 19.39 22.52
Net Profit Margin (%)
6.99 23.85 14.67 14.7

Senores Pharmaceuticals Ltd. Shareholding

All Data in Percentage (%)

Jun 25 Mar 25
Promoter 45.80 45.80
FII 3.70 4.20
MF 3.00 3.20
Others 6.50 6.40
Shareholder Shares Holding %
Download Our App On: